What are the contributing factors for Glucagon-like Peptide-1 (GLP-1) Agonists market growth
Osteoarthritis: Degenerative joint disease that leads to cartilage breakdown, stiffness, and elbow pain , especially with age
The underlying mechanisms may involve factors with sex-specific roles in CVD, such as testosterone
Vitamin levels: To identify deficiencies that can slow metabolism or affect energy
GLP-1s as additive value, not SGLT2i competition KDIGOs 2024 CKD guideline reinforced a shift toward multi-mechanism CKD management, positioning GLP-1s as additive, rather than competitive, with Sodium-Glucose Cotransporter-2 inhibitors (SGLT2i)
Ipamorelin is a pentapeptide compound and a growth hormone releasing peptide that functions as a selective growth hormone secretagogue (National Library of Medicine), stimulating the pituitary gland to release more human growth hormones